79 related articles for article (PubMed ID: 8904149)
1. Drug resistant Pseudomonas aeruginosa bacteremia in HIV-infected patients.
Tacconelli E; Tumbarello M; Ventura G; Lucia MB; Caponera S; Cauda R
J Chemother; 1995 Nov; 7 Suppl 4():180-3. PubMed ID: 8904149
[No Abstract] [Full Text] [Related]
2. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
3. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
Gobernado M
Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
[No Abstract] [Full Text] [Related]
4. [Pseudomonas aeruginosa bacteremia in patients with HIV infection: clinicoepidemiologic study of 17 episodes].
Salavert Lletí S; Navarro Ibáñez V; Roig Rico P; Bretón Martínez JR; Ponz Díez F; López Aldeguer J; Gobernado Serrano M
Rev Clin Esp; 1996 Oct; 196(10):684-91. PubMed ID: 9005471
[TBL] [Abstract][Full Text] [Related]
5. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa bloodstream infections: how should we treat them?
van Delden C
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S71-5. PubMed ID: 17698326
[TBL] [Abstract][Full Text] [Related]
7. [Pseudomonas aeruginosa as a pathogen in patients with human immunodeficiency virus infection].
Vidal Marsal F; Mensa Pueyo J
Rev Clin Esp; 1998 Sep; 198 Suppl 2():37-43. PubMed ID: 9844477
[No Abstract] [Full Text] [Related]
8. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
9. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission.
Tacconelli E; D'Agata EM; Karchmer AW
Clin Infect Dis; 2003 Sep; 37(5):644-9. PubMed ID: 12942394
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia.
Scheetz MH; Bolon MK; Scarsi KK; Fotis MA; Postelnick MJ
J Infect; 2006 Feb; 52(2):105-10. PubMed ID: 15904961
[TBL] [Abstract][Full Text] [Related]
12. [The spectrum of bronchopulmonary infection caused by Pseudomonas aeruginosa in patients infected with the human immunodeficiency virus].
Santín Cerezales M; Aranda Sánchez M; Podzamczer Palter D; Maiques Llacer JM; Rufí Rigau G; Gudiol Munté F
Rev Clin Esp; 1996 Oct; 196(10):692-7. PubMed ID: 9005472
[TBL] [Abstract][Full Text] [Related]
13. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
14. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species.
Rahal JJ
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S95-9. PubMed ID: 16894522
[TBL] [Abstract][Full Text] [Related]
15. Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia.
Paul M; Leibovici L
Lancet Infect Dis; 2005 Apr; 5(4):192-3; discussion 193-4. PubMed ID: 15792730
[No Abstract] [Full Text] [Related]
16. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
Kang CI; Kim SH; Kim HB; Park SW; Choe YJ; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):745-51. PubMed ID: 12955633
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
Matinca D; Vancea D; Boboş C; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
[No Abstract] [Full Text] [Related]
18. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
[TBL] [Abstract][Full Text] [Related]
19. An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patients.
Micol JB; de Botton S; Guieze R; Coiteux V; Darre S; Dessein R; Leroy O; Yakoub-Agha I; Quesnel B; Bauters F; Beaucaire G; Alfandari S
Haematologica; 2006 Aug; 91(8):1134-8. PubMed ID: 16885056
[TBL] [Abstract][Full Text] [Related]
20. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki AP
Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
